Brief: Antengene Corp Says China's NMPA Approves IND Application For ATG-022 Study
02/12/2025 10:32
Dec 2 (Reuters) - Antengene Corp Ltd 6996.HK: CHINA'S NMPA APPROVES IND APPLICATION FOR ATG-022 STUDY Further company coverage: 6996.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Antengene
See all newsBiotech firm Antengene's H1 revenue jumps on licensing deals
Brief: Antengene Corp Expects HY Profit Of RMB195 MLN-RMB238 MLN
Brief: Antengene Corp Receives Initial $60 Million Upfront Payment From UCB
Brief: Antengene Corp Intends To Repurchase Up To 67.92 Million Shares
Brief: Antengene Corp Enters Exclusive License Agreement With K2 Therapeutics For Atg-106